Literature DB >> 7093905

Morphologic types of diffuse large-cell lymphoma.

R A Warnke, J A Strauchen, J S Burke, R T Hoppe, B A Campbell, R F Dorfman.   

Abstract

One hundred eighty-seven patients with confirmed diffuse non-Hodgkin's lymphoma were selected from a consecutive series of 391 patients who were evaluated and treated at Stanford University Medical Center. Lymphomas with any degree of nodularity and diffuse lymphomas of "well-differentiated" and "poorly differentiated" lymphocytic type were excluded from this study. Each of four observers identified cases of diffuse large-cell lymphoma from the 187 cases and further subdivided these cases into six morphologic types in accordance with criteria proposed by Strauchen et al. Initial intraobserver and interobserver agreement was relatively low but was greatly enhanced when the initial six morphologic types were grouped as either follicular center-cell or nonfollicular center-cell types. When individual observer results were pooled, statistically significant differences were seen between survival of patients in these two groups, with the patients in the nonfollicular differences were seen between survival of patients in these two groups, with the patients in the nonfollicular center-cell group having a worse prognosis (P = 0.04). This effect of morphologic type appeared to be independent of pathologic stage. Mitotic counts did not correlate with survival.

Entities:  

Mesh:

Year:  1982        PMID: 7093905     DOI: 10.1002/1097-0142(19820815)50:4<690::aid-cncr2820500412>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Prognostic indicators in centroblastic-centrocytic lymphoma.

Authors:  N R Griffin; M R Howard; P Quirke; C J O'Brien; J A Child; C C Bird
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

2.  Primary periosteal lymphoma--rare and unusual.

Authors:  Ibrahim Fikry Abdelwahab; Benjamin Hoch; George Hermann; Stefano Bianchi; Michael J Klein; Dempsey S Springfield
Journal:  Skeletal Radiol       Date:  2006-03-14       Impact factor: 2.199

3.  Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.

Authors:  L J Medeiros; A B Gelb; K Wolfson; R Doggett; B McGregor; R S Cox; S J Horning; R A Warnke
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

4.  Large cell lymphoma: correlation of HIV status and prognosis with differentiation profiles assessed by immunophenotyping.

Authors:  Sugeshnee Pather; Zainab Mohamed; Heather McLeod; Komala Pillay
Journal:  Pathol Oncol Res       Date:  2013-05-15       Impact factor: 3.201

5.  VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections.

Authors:  H Turley; M Jones; W Erber; K Mayne; M de Waele; K Gatter
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.